Translation and cross-cultural adaptation of the Childhood Bladder and Bowel Dysfunction Questionnaire (CBBDQ)

Bernardes, Rejane de Paula; Barroso, Ubirajara; Cordeiro, Daniele B; Scremim, Cleidimara; Lonkhuyzen, Marieke L. van Engelenburg-van; Bie, Robert de

doi:10.1016/j.jped.2020.10.016

Cited by 3 publications

(5 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, the way in which the intensity of the investigated symptoms is graded presents great difficulty in application and interpretation. Besides, recently, the translation and cross-cultural adaptation of the Childhood Bladder and Bowel Dysfunction Questionnaire (CBBDQ) was carried out, which will allow the quantitative assessment of BBD in Brazilian children, but it can only be applied up to 12 years of age and a cutoff point was not yet defined for diagnostic purposes ( 14 ).…”

Section: Introductionmentioning

confidence: 99%

Validation of the Vancouver Symptom Score Questionnaire for bladder and bowel dysfunction for Brazilian children and adolescents

et al. 2023

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Validation of the Vancouver Symptom Score Questionnaire for bladder and bowel dysfunction for Brazilian children and adolescents

et al. 2023

View full text Add to dashboard Cite

“…Test−retest reliability was demonstrated by an ICC value of 0.97 (CBBDQ: ICC agreement : 0.94). The Brazilian 15 version showed internal consistencies in terms of Cronbach's α values of 0.91−0.96. The Korean and Danish CBBDQs are also available but are still in the psychometric test phase.…”

Section: Discussionmentioning

confidence: 99%

“…To prevent the use of modified versions of the CBBDQ, a common pitfall in scientific research, 39,42 the CBBDQ has been translated into several languages, 14,15,43 with support from the authors of the original version. The Turkish 14 version showed fair to good internal consistency, as demonstrated by the Cronbach's α (0.71 for the bladder subscale and 0.85 for the bowel subscale), which particularly matches the outcomes of the CBBDQ BLSS (0.74) and CBBDQ BOSS (0.71).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Measurement properties of the childhood bladder and bowel dysfunction questionnaire

van Engelenburg–van Lonkhuyzen,

Bols,

Bastiaenen

et al. 2024

J. pediatr. gastroenterol. nutr.

Self Cite

View full text Add to dashboard Cite

ObjectivesThe childhood bladder and bowel dysfunction questionnaire (CBBDQ) was previously found feasible, structurally valid, with good internal consistency. The purpose of this study was to evaluate the remaining measurement properties according to the COnsensus‐based Standards for the selection of health Measurement INstruments (COSMIN).MethodsA prospective cohort study among parents of children aged 5–12 years was conducted. Calculated were the area under the curve (AUC) (criterion validity, responsiveness, interpretability) and intra‐class correlation coefficients (ICCagreement) (construct validity and test−retest reliability).ResultsOne hundred and seventy‐two parents were included from March 2019 to April 2021. Correlating the bladder subscales of the CBBDQ with the Vancouver symptom score for dysfunctional elimination (VSSDES) and proxy‐reported pediatric incontinence quality of life (p‐PinQ) showed convergent validity (ICCsagreement: 0.76 and 0.74). Divergent validity was found when correlating the bowel subscales of the CBBDQ with the VSSDES (ICCagreement: 0.52). Excellent criterion validity (AUC: 0.98); excellent test−retest reliability (ICCagreement: 0.94) and, at 6 months, fair responsiveness (AUC: 0.74) were found. The minimal important change was 4.5, with cut‐off value of 11.ConclusionThe CBBDQ has been developed according to COSMIN standards. The items were defined using the consensus‐based ICCS standards and Rome‐III criteria. The measurement properties were identified using enough participants. Although interpretability is not considered a measurement property, interpretability aspects are reported here as they refer to what instrument scores mean. The 18‐item‐CBBDQ met the measurement properties of validity, reliability, and responsiveness, as defined by COSMIN. The CBBDQ is suitable for self‐administration by parents, and completion takes little time.

show abstract

“…There have been several studies validating crosscultural adaptation with a Cronbach's a of 0.91-0.96. 21,22 The Bristol Stool Scale is a useful screening tool which has been validated for the evaluation of constipation. 23 The cost analysis of medications prior to pediatric urology referral was carried out be calculating the average cost per day based on defined daily dose as listed by the World Health Organization Collaborating Center for Drugs Statistics Methodology (www.…”

Section: Methodsmentioning

confidence: 99%

Neuropsychiatric Developmental Disorders in Children Are Associated With an Impaired Response to Treatment in Bladder Bowel Dysfunction: A Prospective Multi-Institutional European Observational Study

O’Kelly,

t’Hoen,

Silay

et al. 2023

Journal of Urology

View full text Add to dashboard Cite

Purpose: Bladder and bowel dysfunction is a common but underdiagnosed pediatric entity which may represent up to 47% of pediatric urology consults. The objectives of this observational study were to determine functional 1-year outcomes following standard treatment of bladder and bowel dysfunction in both control and neuropsychiatric developmental disorder groups using validated questionnaires, and to perform an initial cost analysis. Materials and Methods: This was a prospective observational study conducted across a number of academic European centers (July 2020-November 2022) for new bladder and bowel dysfunction patients. Parents completed a sociodemographic survey, information pertaining to prior neuropsychiatric developmental disorder diagnoses, as well as a number of validated functional scores. Results: A total of 240 patients were recruited. In the control bladder and bowel dysfunction group, the baseline Dysfunctional Voiding Scoring System and Childhood Bladder and Bowel Dysfunction Questionnaire scores were 20% and 17.% lower, respectively, after 1 year compared to the neuropsychiatric developmental disorder group. The change in improvement was diminished for the neuropsychiatric developmental disorder cohort in both Dysfunctional Voiding Scoring System and Childhood Bladder and Bowel Dysfunction Questionnaire scores. The odds ratio of full symptom resolution was 5.7 in the control cohort compared to the neuropsychiatric developmental disorder cohort. A cost analysis on prescribed medications at referral led to a total cost of €32,603.76 (US $35,381.00) in the control group and €37,625.36 (US $40,830.00) in the neuropsychiatric developmental disorder group. Conclusions: This study demonstrates that pediatric patients with a neuropsychiatric developmental disorder exhibit more severe bladder and bowel dysfunction at baseline and throughout treatment with a lower overall quality of life, as well as 15.4% higher medication costs at referral. It is also important that parents' and

show abstract

Translation and cross-cultural adaptation of the Childhood Bladder and Bowel Dysfunction Questionnaire (CBBDQ)

Cited by 3 publications

References 15 publications

Validation of the Vancouver Symptom Score Questionnaire for bladder and bowel dysfunction for Brazilian children and adolescents

Validation of the Vancouver Symptom Score Questionnaire for bladder and bowel dysfunction for Brazilian children and adolescents

Measurement properties of the childhood bladder and bowel dysfunction questionnaire

Neuropsychiatric Developmental Disorders in Children Are Associated With an Impaired Response to Treatment in Bladder Bowel Dysfunction: A Prospective Multi-Institutional European Observational Study

Contact Info

Product

Resources

About